Ann: Suspension from Official Quotation, page-4

I suspect it was in halt as the SP was moving up, and the professor's 9Michael Fahey) report was done, or almost done, and they wanted to go into halt so there was no risk of insider trading...

Assuming good news from the trial... What is interesting is Michal Fahey has done a fair amount of work in Cerebral Palsy... which interestingly is their next P1/2 trial... as per the recent investor presentation on the GC... Could kick off this quarter... So would make sense if he will lead that trial up too... Unless his tardiness on finalising these results has got NTI Management thinking otherwise... 5 of his last 8 reseasch articles (as listed on the Monash Uni website are Cerebral Palsy related).... i.e. it is his primary expertise....

So why has the Cerebral Palsy come seemingly out of nowhere (compared to say MS)... To be the next P1/2 trial.... Because this bloke has been pushing hard for it... Probably because it is working in ASD.... Just joining the dots here...